Stroke: a case review.
Stroke is indicated by an abrupt manifestation of neurologic deficits secondary to an ischemic or hemorrhagic insult to a region of the brain. Stroke is ranked as the third leading cause of death in the United States, affects more than 730,000 individuals per year, and accounts for 160,000 deaths annually. Approximately $40 billion is spent annually for health care treating stroke victims. This case report shows that despite the use of antithrombotic and/or antiplatelet aggregating drugs, the key to stroke management is primary prevention.
Meister
J
J
Coronary Care Unit, Long Island Jewish Medical Center, New Hyde Park, New York, USA. Vibtach@Medscape.com
Levy
D
D
D000368:Aged; D000369:Aged, 80 and over; D002423:Cause of Death; D004562:Electrocardiography; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D017048:Health Care Costs / Q000706:statistics & numerical data; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011322:Primary Prevention / Q000379:methods; D012307:Risk Factors; D020521:Stroke / Q000097:blood / Q000175:diagnosis* / Q000191:economics / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D014057:Tomography, X-Ray Computed; D014481:United States / Q000453:epidemiology
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors